These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 26258493)
1. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status. Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of glutaminase 2 in human liver and colon cancers. Zhang J; Wang C; Chen M; Cao J; Zhong Y; Chen L; Shen HM; Xia D BMC Cancer; 2013 Dec; 13():601. PubMed ID: 24330717 [TBL] [Abstract][Full Text] [Related]
3. Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma. Majewska E; Rola R; Barczewska M; Marquez J; Albrecht J; Szeliga M J Physiol Pharmacol; 2017 Apr; 68(2):209-214. PubMed ID: 28614770 [TBL] [Abstract][Full Text] [Related]
4. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype. Szeliga M; Albrecht J Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918 [TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
6. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter. Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339 [TBL] [Abstract][Full Text] [Related]
7. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation. Liu F; Cox CD; Chowdhury R; Dovek L; Nguyen H; Li T; Li S; Ozer B; Chou A; Nguyen N; Wei B; Antonios J; Soto H; Kornblum H; Liau L; Prins R; Nghiemphu PL; Yong W; Cloughesy T; Lai A J Neurooncol; 2019 May; 142(3):423-434. PubMed ID: 30838489 [TBL] [Abstract][Full Text] [Related]
8. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma. Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111 [TBL] [Abstract][Full Text] [Related]
9. TP53 promoter methylation in human gliomas. Amatya VJ; Naumann U; Weller M; Ohgaki H Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme. Ghasemi A; Fallah S; Ansari M Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in astrocytic gliomas. Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314 [TBL] [Abstract][Full Text] [Related]
12. TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status. Jesionek-Kupnicka D; Szybka M; Malachowska B; Fendler W; Potemski P; Piaskowski S; Jaskolski D; Papierz W; Skowronski W; Och W; Kordek R; Zawlik I DNA Cell Biol; 2014 Apr; 33(4):217-26. PubMed ID: 24506545 [TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas. Waha A; Felsberg J; Hartmann W; Hammes J; von dem Knesebeck A; Endl E; Pietsch T; Waha A Int J Cancer; 2012 Aug; 131(3):612-22. PubMed ID: 21901745 [TBL] [Abstract][Full Text] [Related]
14. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
15. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645 [TBL] [Abstract][Full Text] [Related]
16. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394 [TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines. Kadowaki M; Yoshioka H; Kamitani H; Watanabe T; Wade PA; Eling TE Int J Cancer; 2012 Jan; 130(2):267-77. PubMed ID: 21437897 [TBL] [Abstract][Full Text] [Related]
19. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Pogribny IP; James SJ Cancer Lett; 2002 Feb; 176(2):169-74. PubMed ID: 11804744 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Waha A; Felsberg J; Hartmann W; von dem Knesebeck A; Mikeska T; Joos S; Wolter M; Koch A; Yan PS; Endl E; Wiestler OD; Reifenberger G; Pietsch T; Waha A Cancer Res; 2010 Feb; 70(4):1689-99. PubMed ID: 20124482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]